OTC: EKTAY - Elekta AB (publ)

Yield per half year: -22.71%
Dividend yield: +3.79%
Sector: Healthcare

Elekta AB (publ)

9.009.008.008.007.007.006.006.005.005.00May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
23.17 31.39 -26.19% 17.49 +32.48%
P/S 1.67 3.24 -48.66%
P/BV 2.8 3.11 -9.88%
P/FCF 3.19 16.62 -80.77%
Ev/Ebitda 10.54 10.15 3.85%
Ev/S 1.91 1.92 -0.5014%
Ev/FCF 42.41 13.61 211.58%
E/P 0.4989 1.47 -66.07%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
6/10
18.14 25 -27.44% 18.45 -1.72%
ROE 12.7 13.27 -4.32%
ROA 4.27 6.22 -31.42%
ROIC 11.86 15.56 -23.78%
ROS 7.19 12.78 -43.74%
ROCE 19.94 12.36 61.27%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
6/10
2.21 6.27 -64.84% 2.18 +1.36%
Nеt Debt/Ebitda 1.36 -5.75 -123.68%
Debt/Ratio 0.2307 0.2158 6.91%
Debt/Equity 3.76 3.24 16.05%
Debt/Net Income 5.57 15.22 -63.43%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
9.48/10
3.79 1.53 147.31% 2.78 +36.42%
Number of years of dividend growth 0 1.3 -100%
DSI 0.8571 0.7874 8.86%
Average dividend growth 7.73 -247.1 -103.13%
Average percentage for 5 years 2.78 2.81 -1%
Average percentage for payments 63.03 245.62 -74.34%
Difference from average difference in sector 2.26

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
24.09 53.19 -54.71%
Growth impulse Ebitda in 5 years 11.65 39.91 -70.81%
Growth impulse Net Income in 5 years 20.11 46.39 -56.65%
Growth impulse FCF in 5 years 224.21 26.84 735.36%
Growth impulse EPS in 5 years 19.99 106.95 -81.31%
IP Score
5.83/10

Similar companies

WuXi Biologics (Cayman) Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription